Review



neutralizing antibodies against cytokines ifn-lambda  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    R&D Systems neutralizing antibodies against cytokines ifn-lambda
    (6a). The effects of nanoparticles on isolated BDCA3+ myeloid dendritic cells and DC SIGN positive monocyte DCs was studied by incubating them overnight with NP-FMP (peptide concentration 0.05μg/ml) at 37°C. The supernatants were then collected and analyzed by VeriPlex™ Human Cytokine ELISA Kit. BDCA3+ MDCs and DC-SIGN DCs incubated alone were used as negative controls. The graph shows mean cytokine expression levels (IL-15, <t>IFN-lambda,</t> TNFα, IL-6 and IL8) per 30,000 APCs ± standard error of the mean for cells obtained from 3 different healthy donors. * p<0.05
    Neutralizing Antibodies Against Cytokines Ifn Lambda, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 7 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/neutralizing antibodies against cytokines ifn-lambda/product/R&D Systems
    Average 90 stars, based on 7 article reviews
    neutralizing antibodies against cytokines ifn-lambda - by Bioz Stars, 2026-03
    90/100 stars

    Images

    1) Product Images from "Nanoparticle-mediated combinatorial targeting of multiple human dendritic cell (DC) subsets leads to enhanced T cell activation via IL-15-dependent DC crosstalk"

    Article Title: Nanoparticle-mediated combinatorial targeting of multiple human dendritic cell (DC) subsets leads to enhanced T cell activation via IL-15-dependent DC crosstalk

    Journal: Journal of immunology (Baltimore, Md. : 1950)

    doi: 10.4049/jimmunol.1400489

    (6a). The effects of nanoparticles on isolated BDCA3+ myeloid dendritic cells and DC SIGN positive monocyte DCs was studied by incubating them overnight with NP-FMP (peptide concentration 0.05μg/ml) at 37°C. The supernatants were then collected and analyzed by VeriPlex™ Human Cytokine ELISA Kit. BDCA3+ MDCs and DC-SIGN DCs incubated alone were used as negative controls. The graph shows mean cytokine expression levels (IL-15, IFN-lambda, TNFα, IL-6 and IL8) per 30,000 APCs ± standard error of the mean for cells obtained from 3 different healthy donors. * p<0.05
    Figure Legend Snippet: (6a). The effects of nanoparticles on isolated BDCA3+ myeloid dendritic cells and DC SIGN positive monocyte DCs was studied by incubating them overnight with NP-FMP (peptide concentration 0.05μg/ml) at 37°C. The supernatants were then collected and analyzed by VeriPlex™ Human Cytokine ELISA Kit. BDCA3+ MDCs and DC-SIGN DCs incubated alone were used as negative controls. The graph shows mean cytokine expression levels (IL-15, IFN-lambda, TNFα, IL-6 and IL8) per 30,000 APCs ± standard error of the mean for cells obtained from 3 different healthy donors. * p<0.05

    Techniques Used: Isolation, Concentration Assay, Enzyme-linked Immunosorbent Assay, Incubation, Expressing



    Similar Products

    neutralizing antibodies against cytokines ifn-lambda  (R&D Systems)
    90
    R&D Systems neutralizing antibodies against cytokines ifn-lambda
    (6a). The effects of nanoparticles on isolated BDCA3+ myeloid dendritic cells and DC SIGN positive monocyte DCs was studied by incubating them overnight with NP-FMP (peptide concentration 0.05μg/ml) at 37°C. The supernatants were then collected and analyzed by VeriPlex™ Human Cytokine ELISA Kit. BDCA3+ MDCs and DC-SIGN DCs incubated alone were used as negative controls. The graph shows mean cytokine expression levels (IL-15, <t>IFN-lambda,</t> TNFα, IL-6 and IL8) per 30,000 APCs ± standard error of the mean for cells obtained from 3 different healthy donors. * p<0.05
    Neutralizing Antibodies Against Cytokines Ifn Lambda, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/neutralizing antibodies against cytokines ifn-lambda/product/R&D Systems
    Average 90 stars, based on 1 article reviews
    neutralizing antibodies against cytokines ifn-lambda - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    (6a). The effects of nanoparticles on isolated BDCA3+ myeloid dendritic cells and DC SIGN positive monocyte DCs was studied by incubating them overnight with NP-FMP (peptide concentration 0.05μg/ml) at 37°C. The supernatants were then collected and analyzed by VeriPlex™ Human Cytokine ELISA Kit. BDCA3+ MDCs and DC-SIGN DCs incubated alone were used as negative controls. The graph shows mean cytokine expression levels (IL-15, IFN-lambda, TNFα, IL-6 and IL8) per 30,000 APCs ± standard error of the mean for cells obtained from 3 different healthy donors. * p<0.05

    Journal: Journal of immunology (Baltimore, Md. : 1950)

    Article Title: Nanoparticle-mediated combinatorial targeting of multiple human dendritic cell (DC) subsets leads to enhanced T cell activation via IL-15-dependent DC crosstalk

    doi: 10.4049/jimmunol.1400489

    Figure Lengend Snippet: (6a). The effects of nanoparticles on isolated BDCA3+ myeloid dendritic cells and DC SIGN positive monocyte DCs was studied by incubating them overnight with NP-FMP (peptide concentration 0.05μg/ml) at 37°C. The supernatants were then collected and analyzed by VeriPlex™ Human Cytokine ELISA Kit. BDCA3+ MDCs and DC-SIGN DCs incubated alone were used as negative controls. The graph shows mean cytokine expression levels (IL-15, IFN-lambda, TNFα, IL-6 and IL8) per 30,000 APCs ± standard error of the mean for cells obtained from 3 different healthy donors. * p<0.05

    Article Snippet: In additional experiments, neutralizing antibodies against cytokines IL-15, IFN-lambda, IL-6 or isotype control mouse IgG1 (all 10μg/ml, R&D) were added to the combinatorial targeting condition.

    Techniques: Isolation, Concentration Assay, Enzyme-linked Immunosorbent Assay, Incubation, Expressing